Z
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
Price:
14.56
CNY
0.76%
Market Closed
Market Cap:
¥4.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
|
CN |
|
R
|
RHT Health Trust
SGX:RF1U
|
SG |
|
J
|
Just Group PLC
LSE:JUST
|
UK |
Cash Flow Statement
Cash Flow Statement
Zhejiang Huakang Pharmaceutical Co Ltd
Zhejiang Huakang Pharmaceutical Co Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
18
|
0
|
0
|
|
| Cash Taxes Paid |
8
|
65
|
82
|
95
|
90
|
53
|
61
|
45
|
38
|
6
|
(2)
|
133
|
121
|
174
|
|
| Change in Working Capital |
(125)
|
(26)
|
(28)
|
(175)
|
(180)
|
(211)
|
(232)
|
(190)
|
(186)
|
(211)
|
(187)
|
(646)
|
(510)
|
(591)
|
|
| Cash from Operating Activities |
200
N/A
|
279
+39%
|
223
-20%
|
272
+22%
|
388
+43%
|
562
+45%
|
661
+18%
|
619
-6%
|
416
-33%
|
306
-26%
|
278
-9%
|
146
-47%
|
263
+79%
|
286
+9%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(463)
|
(470)
|
(568)
|
(540)
|
(521)
|
(543)
|
(505)
|
(691)
|
(1 018)
|
(1 327)
|
(1 430)
|
(1 430)
|
(1 130)
|
(844)
|
|
| Other Items |
(218)
|
396
|
513
|
604
|
(349)
|
(402)
|
(513)
|
(568)
|
(258)
|
(174)
|
(273)
|
(156)
|
(211)
|
(81)
|
|
| Cash from Investing Activities |
(681)
N/A
|
(74)
+89%
|
(55)
+26%
|
64
N/A
|
(869)
N/A
|
(946)
-9%
|
(1 018)
-8%
|
(1 259)
-24%
|
(1 276)
-1%
|
(1 502)
-18%
|
(1 703)
-13%
|
(1 586)
+7%
|
(1 342)
+15%
|
(925)
+31%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
77
|
0
|
0
|
85
|
8
|
0
|
0
|
|
| Net Issuance of Debt |
105
|
416
|
454
|
505
|
807
|
740
|
644
|
1 839
|
1 528
|
1 009
|
1 046
|
(115)
|
314
|
806
|
|
| Cash Paid for Dividends |
(123)
|
(104)
|
(109)
|
(112)
|
(116)
|
(162)
|
(168)
|
(173)
|
(177)
|
(202)
|
(199)
|
(197)
|
(194)
|
(185)
|
|
| Other |
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
(3)
|
(4)
|
(4)
|
(6)
|
0
|
(231)
|
|
| Cash from Financing Activities |
1 348
N/A
|
310
-77%
|
344
+11%
|
392
+14%
|
690
+76%
|
576
-16%
|
474
-18%
|
1 742
+267%
|
1 426
-18%
|
880
-38%
|
928
+5%
|
(311)
N/A
|
122
N/A
|
397
+225%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
(2)
|
(0)
|
(2)
|
5
|
3
|
5
|
5
|
1
|
4
|
4
|
7
|
11
|
11
|
10
|
|
| Net Change in Cash |
866
N/A
|
515
-41%
|
510
-1%
|
733
+44%
|
211
-71%
|
197
-7%
|
122
-38%
|
1 104
+805%
|
570
-48%
|
(311)
N/A
|
(490)
-57%
|
(1 739)
-255%
|
(945)
+46%
|
(233)
+75%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(263)
N/A
|
(191)
+27%
|
(345)
-81%
|
(268)
+22%
|
(133)
+50%
|
18
N/A
|
156
+746%
|
(71)
N/A
|
(602)
-745%
|
(1 021)
-70%
|
(1 151)
-13%
|
(1 283)
-11%
|
(867)
+32%
|
(558)
+36%
|
|
Switch to:
Switch to:
See Also
Discover More
